UiPath delivers automation software and AI-driven solutions to streamline enterprise workflows across major global industries.

Enterprise-wide AI success requires a framework to operationalize AI across healthcare organizations and scale beyond pilot projects.

Q1 FY2027 earnings call recap: raised guidance, ARR/revenue beats, GAAP profit, AI agents & orchestration momentum, buybacks—read now.

UiPath Fell on Good News-That Could Be the Opportunity UiPath (NYSE:PATH) reported a stronger-than-expected start to fiscal ...

UiPath's latest product session was billed as an investor briefing, but the most consequential announcement was a pivot in who - or what - the platform is actually built for. Most enterprise AI ...

UiPath Inc. (NYSE: PATH) is one of the worst-performing agentic AI stocks so far in 2026. Based on its January 2, 2026 close of $16.59 and its April 2, 2026 close of $11.24, the stock was down about ...

UiPath Inc. (NYSE: PATH) is one of the worst-performing agentic AI stocks so far in 2026. Based on its January 2, 2026 close of $16.59 and its April 2, 2026 close of $11.24, the stock was down about ...

UiPath (PATH) is a leading company in the robotic process automation "RPA" space within the software industry. UiPath was founded back in 2005 and has a significant first-mover advantage within the ...

UiPath PATH-1.28%decrease; red down pointing triangle reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for a slowdown in full-year ...

Artificial intelligence (AI) is changing the world we live in, and the next big change is coming in the form of AI agents. Many agentic AI stocks have been thrown out with the bathwater during the ...